BioLineRx Ltd (BLRX) — Capital Reinvestment Ratio

Latest as of December 2023: 0.00x

BioLineRx Ltd (BLRX) has a Capital Reinvestment Ratio of 0.00x as of December 2023, meaning it reinvests 0% of its operating cash flow ($4.99 Million) in capital expenditures ($18.00K). Check BioLineRx Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$4.99 Million
USD

Capital Expenditures

$18.00K
USD

Data as of

Dec 2023
Most recent filing

BioLineRx Ltd Capital Reinvestment Ratio (2010–2010)

This chart tracks BioLineRx Ltd's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see BioLineRx Ltd (BLRX) cash flow conversion.

Annual Capital Reinvestment Ratio for BioLineRx Ltd (2010–2010)

Year-by-year Capital Reinvestment Ratio for BioLineRx Ltd from 2010 to 2010. See BLRX FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2010 0.06x $11.46 Million $660.94K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow